Clinical Research Sites in Venezuela: Top Cities, Hospitals, and Investigator Networks
A detailed guide to clinical research sites across Venezuela — from Caracas to Maracaibo — covering hospital infrastructure, investigator qualifications, and site selection criteria for international sponsors.
July 3, 2026
13
min read
By
bioaccess® Editorial Team
clinical research sites Venezuela
Venezuela hospitals clinical trials
Caracas clinical research
Venezuela investigators
GCP-trained investigators Venezuela
**Key Takeaways**
- • 4 major cities: Caracas, Valencia, Maracaibo, and Barquisimeto offer clinical research infrastructure
- • 60,000+ physicians with many GCP-trained and internationally experienced
- • Private hospital sector remains fully operational with modern equipment
- • bioaccess® has pre-qualified investigators across all major cities
- • Multi-site and multi-country trials supported through bioaccess® network
Clinical research infrastructure in Venezuela
Venezuela's clinical research landscape is anchored by a robust private hospital sector that has maintained high-quality infrastructure despite economic challenges. For sponsors evaluating first-in-human clinical trials in Venezuela, the country offers well-equipped facilities with experienced investigators across multiple therapeutic areas.
bioaccess®, as the first CRO to establish clinical trial operations in Venezuela, has mapped the country's clinical research capabilities and identified top-tier sites across four major cities.
Caracas: the capital hub
Caracas, Venezuela's capital and largest city, is the primary center for clinical research in the country. The city offers:
- Largest concentration of private hospitals and specialty clinics
- Teaching hospitals with active research programs
- Access to specialists across all therapeutic areas
- International airport (Simón Bolívar) for sponsor and monitor travel
- Concentration of pharmaceutical companies and regulatory agency offices
Valencia: industrial and medical center
Valencia, Venezuela's third-largest city and a major industrial center, offers a growing clinical research infrastructure:
- Strong private hospital network with modern diagnostic capabilities
- Large patient population with diverse disease profiles
- Well-connected by highway to Caracas (2 hours) for monitoring visits
- University medical centers with research-oriented faculty
- Lower operational costs than Caracas while maintaining quality
Maracaibo: western Venezuela
Maracaibo, the capital of Zulia state and Venezuela's second-largest city, serves as the western hub for clinical research:
- Major university hospital (Hospital Universitario de Maracaibo) with research tradition
- Large patient catchment area covering western Venezuela
- Specialty expertise in cardiovascular, metabolic, and tropical diseases
- International airport for direct travel access
- Diverse patient demographics for enrollment diversity
Barquisimeto: central-western hub
Barquisimeto, Venezuela's fourth-largest city, offers additional site options:
- Strong medical infrastructure for a mid-sized city
- University-affiliated hospitals with research capacity
- Strategic geographic location in central-western Venezuela
- Treatment-naïve patient populations in surrounding areas
- Cost-effective site option for multi-center studies
Investigator qualifications and capabilities
Venezuelan investigators bring strong qualifications to clinical research:
| Qualification | Availability | Notes |
|---|---|---|
| MD with specialty training | High | Strong medical education system |
| ICH-GCP certification | Moderate-High | bioaccess® provides training as needed |
| Prior clinical trial experience | Moderate | Growing with bioaccess® operations |
| International training/fellowship | Moderate | Many trained in US/EU |
| Bilingual (Spanish-English) | Moderate-High | Facilitates sponsor communication |
| Sub-specialty expertise | High | Available across therapeutic areas |
Site selection criteria for sponsors
bioaccess® evaluates potential clinical trial sites in Venezuela using a comprehensive set of criteria:
- Investigator expertise: therapeutic area experience and GCP training
- Patient access: enrollment potential based on disease prevalence and catchment area
- Facility capabilities: laboratory, pharmacy, imaging, and specialty equipment
- Regulatory compliance: clean inspection history and proper documentation systems
- Staff availability: dedicated study coordinators and sub-investigators
- Geographic accessibility: monitoring visit logistics and travel feasibility
- IRB/ethics committee: established, responsive institutional ethics committee
GCP training and staff availability
bioaccess® ensures all investigators and study staff in its Venezuelan network meet international GCP standards. Our training program includes:
- ICH-GCP E6(R2) certification for all PIs and sub-investigators
- Protocol-specific training sessions for each new study
- eCRF/EDC system training for data entry staff
- Safety reporting and pharmacovigilance training
- Ongoing GCP refresher courses and updates
bioaccess® investigator network in Venezuela
bioaccess® has built a pre-qualified investigator network across Venezuela's major cities, enabling rapid site identification and activation for sponsors. Our network includes specialists in cardiology, oncology, neurology, dermatology, ophthalmology, orthopedics, and rare diseases.
**Need sites in Venezuela?**
bioaccess® can identify and activate clinical trial sites in Venezuela within weeks. Contact us for a site feasibility assessment, or explore our site search and selection services.
Frequently asked questions
Get your FIH roadmap for Venezuela
bioaccess® has the sites, investigators, and infrastructure to support your clinical trial in Venezuela.
Get your FIH roadmap
View case studies